AllianceBernstein’s Oric Pharmaceuticals ORIC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $648K | Sell |
63,810
-43,622
| -41% | -$443K | ﹤0.01% | 2502 |
|
|
2025
Q1 | $599K | Buy |
107,432
+53,562
| +99% | +$299K | ﹤0.01% | 2480 |
|
|
2024
Q4 | $435K | Sell |
53,870
-8,000
| -13% | -$64.6K | ﹤0.01% | 2701 |
|
|
2024
Q3 | $634K | Buy |
61,870
+17,820
| +40% | +$183K | ﹤0.01% | 2552 |
|
|
2024
Q2 | $311K | Buy |
44,050
+13,890
| +46% | +$98.2K | ﹤0.01% | 2902 |
|
|
2024
Q1 | $415K | Buy |
30,160
+14,840
| +97% | +$204K | ﹤0.01% | 2665 |
|
|
2023
Q4 | $141K | Buy |
+15,320
| New | +$141K | ﹤0.01% | 3024 |
|
|
2022
Q2 | – | Sell |
-33,100
| Closed | -$177K | – | 3333 |
|
|
2022
Q1 | $177K | Buy |
33,100
+100
| +0.3% | +$535 | ﹤0.01% | 3004 |
|
|
2021
Q4 | $485K | Buy |
33,000
+4,700
| +17% | +$69.1K | ﹤0.01% | 2750 |
|
|
2021
Q3 | $592K | Hold |
28,300
| – | – | ﹤0.01% | 2688 |
|
|
2021
Q2 | $501K | Buy |
28,300
+2,400
| +9% | +$42.5K | ﹤0.01% | 2799 |
|
|
2021
Q1 | $635K | Buy |
25,900
+1,100
| +4% | +$27K | ﹤0.01% | 2570 |
|
|
2020
Q4 | $839K | Buy |
24,800
+13,400
| +118% | +$453K | ﹤0.01% | 2364 |
|
|
2020
Q3 | $285K | Buy |
11,400
+1,200
| +12% | +$30K | ﹤0.01% | 2832 |
|
|
2020
Q2 | $344K | Buy |
+10,200
| New | +$344K | ﹤0.01% | 2809 |
|